US Bancorp’s ChemoCentryx, Inc. CCXI Stock Holding History

US Bancorp’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,681	Closed	-$138K	–	4347
2022 Q3	$138K	Sell	2,681 -12	-0.4%	-$496	﹤0.01%	2035
2022 Q2	$66K	Sell	2,693 -732	-21%	-$16.1K	﹤0.01%	2447
2022 Q1	$86K	Buy	3,425 +291	+9%	+$8.18K	﹤0.01%	2351
2021 Q4	$114K	Buy	3,134 +51	+2%	+$1.79K	﹤0.01%	2240
2021 Q3	$53K	Buy	3,083 +1,121	+57%	+$17.5K	﹤0.01%	2625
2021 Q2	$26K	Sell	1,962 -4,253	-68%	-$105K	﹤0.01%	2998
2021 Q1	$318K	Sell	6,215 -327	-5%	-$19.7K	﹤0.01%	1722
2020 Q4	$405K	Buy	6,542 +3,306	+102%	+$189K	﹤0.01%	1554
2020 Q3	$177K	Buy	+3,236	New	+$174K	﹤0.01%	1833

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

US Bancorp's CCXI Position: Q4 2022 in Review

US Bancorp sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 2,681 shares — an estimated $138K sold.

US Bancorp first reported a position in CCXI in Q3 2020 and held it in 9 quarters. The position peaked at $405K in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

US Bancorp reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
US Bancorp sold 2,681 ChemoCentryx, Inc. shares in Q4 2022, an estimated $138K.
US Bancorp first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 9 quarters.
US Bancorp's ChemoCentryx, Inc. position peaked at $405K in Q4 2020.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on US Bancorp's 13F filing for Q4 2022, filed 13 Feb 2023.